help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2003
Endocrinology, doi:10.1210/en.2003-0289
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/9/3934    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sunny Sun, H.
Right arrow Articles by Tsai, S.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sunny Sun, H.
Right arrow Articles by Tsai, S.-J.

Submitted on March 5, 2003
Accepted on May 21, 2003

Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells is mediated by the prostaglandin EP2 receptor

H. Sunny Sun1, Kuei-Yang Hsiao1, Chih-Chao Hsu1, Meng-Hsing Wu1, and Shaw-Jenq Tsai1*

1 Institute of Molecular Medicine , Department of Physiology , Department of Obstetrics & Gynecology and Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan 70101, Taiwan, Republic of China

* To whom correspondence should be addressed. E-mail: seantsai{at}mail.ncku.edu.tw.

Steroidogenic acute regulatory protein (StAR) regulates the first committed step in the biosynthesis of steroids and thus aberrant expression of StAR in endometriotic implants plays a critical role in the etiology of endometriosis. However, the mechanism responsible for abnormal expression of StAR in ectopic endometriotic tissues remains unknown. In the present study, we demonstrate that prostaglandin (PG) E2 stimulates StAR protein expression at the cellular and molecular levels. PGE2 caused a rapid increase in StAR expression that involves activation of the EP2 receptor-coupled protein kinase (PK) A pathway. Activation of EP2 receptor induced phosphorylation of extracellular signal-regulated protein kinase (ERK) and cAMP responding element binding protein (CREB). However, activation of ERK did not involve in CREB phosphorylation or concomitantly StAR expression. Phosphorylation of CREB induced by PGE2 increased the recruitment of CREB-binding protein (CBP) and thus histone H3 acetylation. Chromatin immunoprecipitation experiments showed that acetylated histone H3 bound to the proximal region of the StAR promoter was increased after 30 min treatment with PGE2, and this was mirrored by an increase in nascent StAR RNA transcription. Treatment with the histone deacetylase inhibitor, Tricostatin A, enhanced PGE2-induced nascent StAR RNA transcription. We conclude that increased histone H3 acetylation involving the EP2 receptor, PKA, CREB, and CBP protein is responsible for PGE2-induced StAR gene activation in endometriotic stromal cells. Our current report may provide new insights in understanding mechanism of abnormally local production of estrogen and the etiology of endometriosis.


Key words: endometriosis • StAR • PGE2 • EP2 • histone acetylation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society